Clinical Trial

Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial

Study acronym: MID-ACT
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated May 8, 2026 (before its estimated June 24, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is an individually randomized cross-over trial to assess acceptability, preference, and perceived side effects of MMS formulations with 30 mg, 45 mg and 60 mg of iron.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-01-23 -> 2026-06-24 2026-05-07
minor Completion pushed: 2026-04-24 -> 2026-06-24 2026-05-07
Trial Details
NCT Number NCT06069869
Lead Sponsor George Washington University
Collaborators: Ifakara Health Institute, Harvard School of Public Health (HSPH), Muhimbili University of Health and Allied Sciences, Africa Academy for Public Health, Columbia University
Conditions Pregnancy Related
Enrollment 156 participants
Start Date 2025-09-26
Primary Completion 2026-06-24 (estimated)
Study Completion 2026-06-24 (estimated)
Updated on ClinicalTrials.gov 2026-05-08